Longitudinal change instead of baseline testosterone predicts depressive symptoms. (March 2018)

• Record Type: Journal Article
• Authors: Kische, Hanna; Pieper, Lars; Venz, John; Klotsche, Jens; März, Winfried; Koch-Gromus, Uwe; Pittrow, David; Lehnert, Hendrik; Silber, Sigmund; Stalla, G.K.; Zeiher, Andreas M.; Wittchen, Hans-Ulrich; Haring, Robin
• Is Part Of: Psychoneuroendocrinology. Volume 89(2018)
• Page Start: 7
• Page End: 12
• Publication Date: 2018-03
• Subjects: Testosterone -- Sex hormone change -- Depression; Psychoneuroendocrinology -- Periodicals; Endocrinology -- Periodicals; Neurology -- Periodicals; Psychiatry -- Periodicals; Neuropsychoendocrinologie -- Périodiques; 616.8
• DOI: 10.1016/j.psyneuen.2017.12.013
• Languages: English
• ISSNs: 0306-4530

Abstract

Highlights: Large-scale longitudinal study with 6493 primary care patients. First study to comparatively investigate the predictive value of T vs. change in T related to incident depressive symptoms. Sex-specific inverse association of T change, but not baseline T, with increased depressive symptom burden in men. Results indicate the importance of assessing repeated measures of sex hormone status. Abstract: Background: The association between total testosterone (T) and depression mostly relies on single sex hormone assessment and remains inconclusive. Thus, we investigated the comparative predictive performance of baseline T and change in T with development of depressive symptoms and incident depressive episodes. Methods: We used data from 6493 primary care patients (2653 men and 3840 women) of the DETECT study (Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment), including four-year follow-up, repeated immunoassay-based measurement of serum T and depressive symptoms assessed by the Depression Screening Questionnaire (DSQ). Cross-sectional and longitudinal associations of baseline T and one-year change in T with prevalent and incident depression were investigated using age- and multivariable-adjusted regression models. Results: Baseline T showed no association with prevalent or incident depressive symptoms and episodes in both sexes. In men, a positive change in T (higher T at one-year follow-up compared to baseline) was associated with a lower burden of depressive symptoms (β-coefficient per unit change in T: −0.17; 95% CI: −0.31 to −0.04) and lower risk of incident depressive symptoms (odds ratio per unit change in T: 0.84; 95% CI: 0.72–0.98) at four-year follow-up. In women, the association of T change with incident depressive episodes was rendered non-significant after multivariable adjustment. Discussion: The present study observed a sex-specific inverse association of T change, but not baseline T, with increased depressive symptom burden in men. Future studies should assess longitudinal changes in sex hormone status as predictor of adverse health outcomes related to low T.